Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report ; volume:15 ; number:1 ; day:19 ; month:12 ; year:2021 ; pages:1-4 ; date:12.2021
Journal of medical case reports ; 15, Heft 1 (19.12.2021), 1-4, 12.2021
- Urheber
-
Qatomah, Abdulrahman
Bukhari, Majidah
Cupler, Edward
Alardati, Hosam
Mawardi, Mohammad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-021-03138-0
- URN
-
urn:nbn:de:101:1-2022041321150449631116
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qatomah, Abdulrahman
- Bukhari, Majidah
- Cupler, Edward
- Alardati, Hosam
- Mawardi, Mohammad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy